Abstract
Growth factors (GFs) are critical biomolecules associated with the maintenance of homeostasis within cardiovascular tissues. They act in a complex time-, concentration-, and microenvironment-determined manner, often in conjunction with each other, to control multiple cellular functions and repair processes at the tissue level. However, exogenous GFs may not be sensed by the target tissue in a time-frame suitable for tissue regeneration, due to their rapid degradation that shortens their half-lives, thereby entailing the need for multiple infusions and/or high dosage. Moreover, excessive GF concentrations and systemic GF delivery can lead to undesirable system-wide pathological responses, highlighting the critical need for their localized delivery to the target tissue site and precise control over GF dosing, activation, and spatiotemporal bioavailability taking into account the specific cardiovascular (CV) tissue microenvironment.
In this chapter, we provide an overview of biomaterials for the delivery of GFs and cells towards the regenerative repair of CV tissues. A variety of natural and synthetic biomaterials, as well as hybrid materials, have shown significant promise as vehicles for controlled presentation or release of GFs, while serving as platforms to modulate phenotype and regenerative potential of cells pre-seeded within or recruited in situ following implantation in the host. Additionally, incorporation of linkages within these scaffolds that can be activated by stimuli prevalent within the target tissue microenvironment can enable “on demand” and spatiotemporally modulated release of one or more GFs. Thus, we submit that these sophisticated delivery systems, coupled with a more comprehensive understanding of the signaling mechanisms underlying CV tissue formation during fetal development, and the identification of the specific GF(s) necessary for desired therapeutic effects will lead to the development of patient- and condition-customized therapies to overcome CV disease pathologies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA et al (2007) Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989–997
Allen JB, Khan S, Lapidos KA, Ameer GA (2010) Toward engineering a human neoendothelium with circulating progenitor cells. Stem Cells 28:318–328
Anderson KM, Odell PM, Wilson PW, Kannel WB (1991) Cardiovascular disease risk profiles. Am Heart J 121:293–298
Anitua E, Sanchez M, Orive G, Andia I (2008) Delivering growth factors for therapeutics. Trends Pharmacol Sci 29:37–41
Anitua E, Sanchez M, Orive G (2010) Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62:741–752
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Astete CE, Sabliov CM (2006) Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 17:247–289
Atala A, Kasper FK, Mikos AG (2012) Engineering complex tissues. Sci Transl Med 4:3004890
Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning RM et al (2008a) Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels. Blood 111:1302–1305
Au P, Tam J, Fukumura D, Jain RK (2008b) Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 111:4551–4558
Babensee JE, McIntire LV, Mikos AG (2000) Growth factor delivery for tissue engineering. Pharm Res 17:497–504
Bashur CA, Venkataraman L, Ramamurthi A (2012) Tissue engineering and regenerative strategies to replicate biocomplexity of vascular elastic matrix assembly. Tissue Eng Part B Rev 18: 203–217
Basmanav FB, Kose GT, Hasirci V (2008) Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 29:4195–4204
Bayes-Genis A, Conover CA, Schwartz RS (2000) The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 86:125–130
Belz GG (1995) Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 9:73–83
Bennett MR (2011) Cell death in cardiovascular disease. Arterioscler Thromb Vasc Biol 31: 2779–2780
Benvenuti LA, Onishi RY, Gutierrez PS, de Lourdes Higuchi M (2005) Different patterns of atherosclerotic remodeling in the thoracic and abdominal aorta. Clinics 60:355–360
Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R et al (2000) Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 95:581–585
Bing RJ (2001) Myocardial ischemia and infarction: growth of ideas. Cardiovasc Res 51:13–20
Black SM, Grobe A, Mata-Greenwood E, Noskina Y (2004) Cyclic stretch increases VEGF expression in pulmonary arterial smooth muscle cells via TGF-1 and reactive oxygen species: a requirement for NAD(P)H oxidase. Conf Proc IEEE Eng Med Biol Soc 7:5053–5056
Bonow RO, Mann DL, Zipes DP, Libby P (2012) Braunwald’s heart disease: a textbook of cardiovascular medicine. Elsevier, Philadelphia, PA
Boontheekul T, Mooney DJ (2003) Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 14:559–565
Boontheekul T, Kong HJ, Mooney DJ (2005) Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26:2455–2465
Boontheekul T, Hill EE, Kong HJ, Mooney DJ (2007) Regulating myoblast phenotype through controlled gel stiffness and degradation. Tissue Eng 13:1431–1442
Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, Lichtman JW et al (2010) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A 107:3287–3292
Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJ (2001) Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog 17:945–950
Brazel CS, Peppas NA (1995) Synthesis and characterization of thermo- and chemomechanically responsive poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. Macromolecules 28:8016–8020
Brown DM, Hong SP, Farrell CL, Pierce GF, Khouri RK (1995) Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc Natl Acad Sci U S A 92:5920–5924
Brown RA, Sethi KK, Gwanmesia I, Raemdonck D, Eastwood M, Mudera V (2002) Enhanced fibroblast contraction of 3D collagen lattices and integrin expression by TGF-beta1 and -beta3: mechanoregulatory growth factors? Exp Cell Res 274:310–322
Bryant SJ, Nuttelman CR, Anseth KS (2000) Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro. J Biomater Sci Polym Ed 11:439–457
Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G et al (2007) Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 116:2127–2138
Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94:664–670
Casanovas J, Zanuy D, Alemán C (2006) Conducting polymer actuator mechanism based on the conformational flexibility of calix[4]arene. Angew Chem Int Ed Engl 45:1103–1105
Casscells W (1991) Smooth muscle cell growth factors. Prog Growth Factor Res 3:177–206
Celletti FL, Waugh JM, Amabile PG, Brendolan A, Hilfiker PR, Dake MD (2001) Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7:425–429
Chang MY, Yang YJ, Chang CH, Tang AC, Liao WY, Cheng FY et al (2013) Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J Control Release 170:287–294
Chapanian R, Amsden BG (2010) Combined and sequential delivery of bioactive VEGF165 and HGF from poly(trimethylene carbonate) based photo-cross-linked elastomers. J Control Release 143:53–63
Chen G, Hoffman AS (1995) Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH. Nature 373:49–52
Chen RR, Mooney DJ (2003) Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 20:1103–1112
Chen RR, Silva EA, Yuen WW, Brock AA, Fischbach C, Lin AS et al (2007a) Integrated approach to designing growth factor delivery systems. FASEB J 21:3896–3903
Chen FM, Zhao YM, Sun HH, Jin T, Wang QT, Zhou W et al (2007b) Novel glycidyl methacrylated dextran (Dex-GMA)/gelatin hydrogel scaffolds containing microspheres loaded with bone morphogenetic proteins: formulation and characteristics. J Control Release 118:65–77
Chen FM, Zhao YM, Zhang R, Jin T, Sun HH, Wu ZF et al (2007c) Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Control Release 121:81–90
Chen RR, Silva EA, Yuen WW, Mooney DJ (2007d) Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24:258–264
Chen FM, Shelton RM, Jin Y, Chapple IL (2009a) Localized delivery of growth factors for periodontal tissue regeneration: role, strategies, and perspectives. Med Res Rev 29:472–513
Chen F-M, Chen R, Wang X-J, Sun H-H, Wu Z-F (2009b) In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 30:5215–5224
Chen FM, Zhang M, Wu ZF (2010) Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31:6279–6308
Cheng XW, Shi GP, Kuzuya M, Sasaki T, Okumura K, Murohara T (2012) Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication. Circulation 125:1551–1562
Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M et al (2011) Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 22:130
Chow D, Nunalee ML, Lim DW, Simnick AJ, Chilkoti A (2008) Peptide-based biopolymers in biomedicine and biotechnology. Mater Sci Eng R Rep 62:125–155
Christman KL, Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48:907–913
Christoffersson G, Vagesjo E, Vandooren J, Liden M, Massena S, Reinert RB et al (2012) VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood 120:4653–4662
Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G (2007) Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 121:91–99
Conti E, Andreotti F, Sestito A, Riccardi P, Menini E, Crea F et al (2002) Reduced levels of insulin-like growth factor-1 in patients with angina pectoris, positive exercise stress test, and angiographically normal epicardial coronary arteries. Am J Cardiol 89:973–975
Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C et al (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260–2265
Cortes-Morichetti M, Frati G, Schussler O, Duong Van Huyen JP, Lauret E, Genovese JA et al (2007) Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 13:2681–2687
Courtney T, Sacks MS, Stankus J, Guan J, Wagner WR (2006) Design and analysis of tissue engineering scaffolds that mimic soft tissue mechanical anisotropy. Biomaterials 27:3631–3638
Crapo PM, Wang Y (2010) Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate. Biomaterials 31:1626–1635
Dahms SE, Piechota HJ, Dahiya R, Lue TF, Tanagho EA (1998) Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol 82:411–419
Dai JP, Losy F, Guinault AM, Pages C, Anegon I, Desgranges P et al (2005a) Overexpression of transforming growth factor-beta 1 stabilizes already-formed aortic aneurysms—a first approach to induction of functional healing by endovascular gene therapy. Circulation 112:1008–1015
Dai W, Wold LE, Dow JS, Kloner RA (2005b) Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 46:714–719
Datta N, Pham QP, Sharma U, Sikavitsas VI, Jansen JA, Mikos AG (2006) In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A 103:2488–2493
Davani EY, Brumme Z, Singhera GK, Cote HC, Harrigan PR, Dorscheid DR (2003) Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. Crit Care 7:10
Davis ME, Hsieh PCH, Grodzinsky AJ, Lee RT (2005) Custom design of the cardiac microenvironment with biomaterials. Circ Res 97:8–15
Davis ME, Hsieh PCH, Takahashi T, Song Q, Zhang S, Kamm RD et al (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 103:8155–8160
de Mel A, Jell G, Stevens MM, Seifalian AM (2008) Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 9:2969–2979
de Souza RR (2002) Aging of myocardial collagen. Biogerontology 3:325–335
Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH et al (2009) Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120:843680
Dietz HC, Pyeritz RE (1995) Mutations in the human gene for fibrillin-1 (FBN1) in the Marfan syndrome and related disorders. Hum Mol Genet 4 Spec No:1799–1809
Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352: 337–339
Dimmeler S, Zeiher AM (2003) Exercise and cardiovascular health: get active to “AKTivate” your endothelial nitric oxide synthase. Circulation 107:3118–3120
Discher DE, Mooney DJ, Zandstra PW (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324:1673–1677
Dong JD, Gu YQ, Li CM, Wang CR, Feng ZG, Qiu RX et al (2009) Response of mesenchymal stem cells to shear stress in tissue-engineered vascular grafts. Acta Pharmacol Sin 30: 530–536
Dubois G, Segers VF, Bellamy V, Sabbah L, Peyrard S, Bruneval P et al (2008) Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium. J Biomed Mater Res B Appl Biomater 87:222–228
Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE et al (2000) Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest 106:55–62
Dvir T, Kedem A, Ruvinov E, Levy O, Freeman I, Landa N et al (2009) Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc Natl Acad Sci U S A 106:14990–14995
Eckhouse SR, Purcell BP, McGarvey JR, Lobb D, Logdon CB, Doviak H et al (2014) Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction. Sci Transl Med 6:3007244
Edep ME, Shirani J, Wolf P, Brown DL (2000) Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol 9:281–286
Eggermann J, Kliche S, Jarmy G, Hoffmann K, Mayr-Beyrle U, Debatin KM et al (2003) Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. Cardiovasc Res 58:478–486
Ehrbar M, Djonov VG, Schnell C, Tschanz SA, Martiny-Baron G, Schenk U et al (2004) Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94:1124–1132
Ehrbar M, Rizzi SC, Hlushchuk R, Djonov V, Zisch AH, Hubbell JA et al (2007) Enzymatic formation of modular cell-instructive fibrin analogs for tissue engineering. Biomaterials 28: 3856–3866
Ehrbar M, Schoenmakers R, Christen EH, Fussenegger M, Weber W (2008) Drug-sensing hydrogels for the inducible release of biopharmaceuticals. Nat Mater 7:800–804
Ehrick JD, Deo SK, Browning TW, Bachas LG, Madou MJ, Daunert S (2005) Genetically engineered protein in hydrogels tailors stimuli-responsive characteristics. Nat Mater 4:298–302
Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P (2002) Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 106:2257–2262
Engelhardt EM, Micol LA, Houis S, Wurm FM, Hilborn J, Hubbell JA et al (2011) A collagen-poly(lactic acid-co-varepsilon-caprolactone) hybrid scaffold for bladder tissue regeneration. Biomaterials 32:3969–3976
Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677–689
Eppler SM, Combs DL, Henry TD, Lopez JJ, Ellis SG, Yi JH et al (2002) A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans. Clin Pharmacol Ther 72:20–32
Ertan AB, Yilgor P, Bayyurt B, Calikoglu AC, Kaspar C, Kok FN et al (2013) Effect of double growth factor release on cartilage tissue engineering. J Tissue Eng Regen Med 7:149–160
Feil H, Bae YH, Feijen J, Kim SW (1993) Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers. Macromolecules 26:2496–2500
Freedman SB, Isner JM (2002) Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136:54–71
Freeman I, Cohen S (2009) The influence of the sequential delivery of angiogenic factors from affinity-binding alginate scaffolds on vascularization. Biomaterials 30:2122–2131
Freeman I, Kedem A, Cohen S (2008) The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29:3260–3268
Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145–1151
Fritze O, Romero B, Schleicher M, Jacob MP, Oh DY, Starcher B et al (2012) Age-related changes in the elastic tissue of the human aorta. J Vasc Res 49:77–86
Fujimoto KL, Ma Z, Nelson DM, Hashizume R, Guan J, Tobita K et al (2009) Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium. Biomaterials 30:4357–4368
Gabriel D, Zuluaga MF, van den Bergh H, Gurny R, Lange N (2011) It is all about proteases: from drug delivery to in vivo imaging and photomedicine. Curr Med Chem 18:1785–1805
Gacchina CE, Ramamurthi A (2011) Impact of pre-existing elastic matrix on TGFβ1 and HA oligomer-induced regenerative elastin repair by rat aortic smooth muscle cells. J Tissue Eng Regen Med 5:85–96
Gacchina CE, Deb PP, Barth JL, Ramamurthi A (2011) Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng 17:1699–1711
Galderisi M, Caso P, Cicala S, De Simone L, Barbieri M, Vitale G et al (2002) Positive association between circulating free insulin-like growth factor-1 levels and coronary flow reserve in arterial systemic hypertension. Am J Hypertens 15:766–772
Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis—the good, the bad, and the ugly. Circ Res 90:251–262
Garbern JC, Hoffman AS, Stayton PS (2010) Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules 11:1833–1839
Garbern JC, Minami E, Stayton PS, Murry CE (2011) Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials 32:2407–2416
Gerthoffer WT (2007) Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607–621
Giraud MN, Ayuni E, Cook S, Siepe M, Carrel TP, Tevaearai HT (2008) Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif Organs 32:692–700
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al (2013) Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127:e6–e245
Godier-Furnemont AF, Martens TP, Koeckert MS, Wan L, Parks J, Arai K et al (2011) Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc Natl Acad Sci U S A 108:7974–7979
Golledge J, Norman PE (2009) Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients’ management. Curr Opin Cardiol 24:532–538
Golledge J, Norman PE (2010) Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors? Arterioscler Thromb Vasc Biol 30:1075–1077
Golledge J, Muller J, Daugherty A, Norman P (2006) Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 26:2605–2613
Golub JS, Kim YT, Duvall CL, Bellamkonda RV, Gupta D, Lin AS et al (2010) Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth. Am J Physiol Heart Circ Physiol 298:12
Gong Z, Niklason LE (2008) Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22:1635–1648
Gong CY, Shi S, Peng XY, Kan B, Yang L, Huang MJ et al (2009) Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity. Growth Factors 27:377–383
Gorbet MB, Sefton MV (2004) Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 25:5681–5703
Goumans MJ, Liu Z, ten Dijke P (2009) TGF-beta signaling in vascular biology and dysfunction. Cell Res 19:116–127
Grant MB, Wargovich TJ, Ellis EA, Tarnuzzer R, Caballero S, Estes K et al (1996) Expression of IGF-I, IGF-I receptor and IGF binding proteins-1, -2, -3, -4 and -5 in human atherectomy specimens. Regul Pept 67:137–144
Greisler HP, Cziperle DJ, Kim DU, Garfield JD, Petsikas D, Murchan PM et al (1992) Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 112:244–254, discussion 54–55
Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ et al (2003) Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. Circulation 108:2710–2715
Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon NL, Hughes CC et al (2005) Diffusion limits of an in vitro thick prevascularized tissue. Tissue Eng 11:257–266
Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S et al (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124:175–189
Guo DC, Papke CL, He RM, Milewicz DM (2006) Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci 1085:339–352
Hall JE (2010) Guyton and Hall textbook of medical physiology, 12th edn. Saunders, Philadelphia, PA
Hamdi H, Furuta A, Bellamy V, Bel A, Puymirat E, Peyrard S et al (2009) Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison. Ann Thorac Surg 87: 1196–1203
Harris TJ, von Maltzahn G, Lord ME, Park JH, Agrawal A, Min DH et al (2008) Protease-triggered unveiling of bioactive nanoparticles. Small 4:1307–1312
Helisch A, Ware JA (1999) Therapeutic angiogenesis in ischemic heart disease. Thromb Haemost 82:772–780
Helisch A, Ware JA (2000) Therapeutic angiogenesis for ischemic heart disease. Adv Exp Med Biol 476:327–350
Hellstrom M, Kalen M, Lindahl P, Abramsson A, Betsholtz C (1999) Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047–3055
Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ et al (2003) The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation 107:1359–1365
Hill E, Boontheekul T, Mooney DJ (2006) Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci U S A 103:2494–2499
Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549–580
Holland TA, Tabata Y, Mikos AG (2005) Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101:111–125
Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031–26037
Hristov M, Erl W, Weber PC (2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23:1185–1189
Hsieh PC, Davis ME, Gannon J, MacGillivray C, Lee RT (2006) Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest 116:237–248
Hu SH, Liu TY, Huang HY, Liu DM, Chen SY (2008) Magnetic-sensitive silica nanospheres for controlled drug release. Langmuir 24:239–244
Hu SH, Liu TY, Huang HY, Liu DM, Chen SY (2009) Stimuli-responsive controlled drug release from magnetic-sensitive silica nanospheres. J Nanosci Nanotechnol 9:866–870
Hutchings H, Ortega N, Plouet J (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 17:1520–1522
Hutter R, Sauter BV, Reis ED, Roque M, Vorchheimer D, Carrick FE et al (2003) Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation 107:1658–1663
Iaizzo PA (2009) Handbook of Cardiac Anatomy, Physiology, and Devices, 2nd edn. Humana Press, New York
Ikonomidis JS, Barbour JR, Amani Z, Stroud RE, Herron AR, McClister DM et al (2005) Effects of deletion of the matrix metalloproteinase 9 gene on development of murine thoracic aortic aneurysms. Circulation 112:I242–I248
Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R et al (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98: 2108–2116
Inoue T, Croce K, Morooka T, Sakuma M, Node K, Simon DI (2011) Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis. JACC Cardiovasc Interv 4:1057–1066
Ito Y (2008) Covalently immobilized biosignal molecule materials for tissue engineering. Soft Matter 4:46–56
Izhar U, Hasdai D, Richardson DM, Cohen P, Lerman A (2000) Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro. Coron Artery Dis 11:69–76
Jackson CL, Raines EW, Ross R, Reidy MA (1993) Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler Thromb 13:1218–1226
Jager EW, Smela E, Inganas O (2000) Microfabricating conjugated polymer actuators. Science 290:1540–1545
Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E (2008) Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29:1518–1525
Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW (1992) Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89:507–511
Jeong B, Kim SW, Bae YH (2002a) Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 54:37–51
Jeong B, Lee KM, Gutowska A, An YH (2002b) Thermogelling biodegradable copolymer aqueous solutions for injectable protein delivery and tissue engineering. Biomacromolecules 3: 865–868
Jiang B, Zhang G, Brey EM (2013) Dual delivery of chlorhexidine and platelet-derived growth factor-BB for enhanced wound healing and infection control. Acta Biomater 9:4976–4984
Jin H, Wyss JM, Yang R, Schwall R (2004) The therapeutic potential of hepatocyte growth factor for myocardial infarction and heart failure. Curr Pharm Des 10:2525–2533
Jin J, Jeong SI, Shin YM, Lim KS, Shin H, Lee YM et al (2009) Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur J Heart Fail 11:147–153
Joddar B, Ramamurthi A (2006a) Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 27:2994–3004
Joddar B, Ramamurthi A (2006b) Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells. Biomaterials 27:5698–5707
Joddar B, Ibrahim S, Ramamurthi A (2007) Impact of delivery mode of hyaluronan oligomers on elastogenic responses of adult vascular smooth muscle cells. Biomaterials 28:3918–3927
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48:193–202
Joshi RV, Nelson CE, Poole KM, Skala MC, Duvall CL (2013) Dual pH- and temperature-responsive microparticles for protein delivery to ischemic tissues. Acta Biomater 9: 6526–6534
Kaden JJ, Vocke DC, Fischer CS, Grobholz R, Brueckmann M, Vahl CF et al (2004) Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis. Z Kardiol 93:124–130
Kang TY, Hong JM, Kim BJ, Cha HJ, Cho DW (2013) Enhanced endothelialization for developing artificial vascular networks with a natural vessel mimicking the luminal surface in scaffolds. Acta Biomater 9:4716–4725
Karnik SK, Brooke BS, Bayes-Genis A, Sorensen L, Wythe JD, Schwartz RS et al (2003) A critical role for elastin signaling in vascular morphogenesis and disease. Development 130: 411–423
Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM (1997) Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 151:1775–1784
Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW et al (2001) Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 7:1035–1040
Khabbaz KR, Zankoul F, Warner KG (2001) Intraoperative metabolic monitoring of the heart: II. Online measurement of myocardial tissue pH. Ann Thorac Surg 72:S2267–S2270
Kielty CM, Baldock C, Lee D, Rock MJ, Ashworth JL, Shuttleworth CA (2002) Fibrillin: from microfibril assembly to biomechanical function. Philos Trans R Soc Lond B Biol Sci 357: 207–217
Kim BS, Nikolovski J, Bonadio J, Mooney DJ (1999) Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 17:979–983
Kim JH, Jung Y, Kim SH, Sun K, Choi J, Kim HC et al (2011) The enhancement of mature vessel formation and cardiac function in infarcted hearts using dual growth factor delivery with self-assembling peptides. Biomaterials 32:6080–6088
Kimura Y, Tabata Y (2010) Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 21:37–51
Kirkland RA, Saavedra GM, Franklin JL (2007) Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution. J Neurosci 27:11315–11326
Klouda L, Mikos AG (2008) Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 68:34–45
Kloxin AM, Kasko AM, Salinas CN, Anseth KS (2009) Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 324:59–63
Ko IK, Ju YM, Chen T, Atala A, Yoo JJ, Lee SJ (2012) Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration. FASEB J 26:158–168
Ko IK, Lee SJ, Atala A, Yoo JJ (2013) In situ tissue regeneration through host stem cell recruitment. Exp Mol Med 15:118
Kobayashi H, DeBusk LM, Babichev YO, Dumont DJ, Lin PC (2006) Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 108:1260–1266
Kothapalli CR, Ramamurthi A (2008) Benefits of concurrent delivery of hyaluronan and IGF-1 cues to regeneration of crosslinked elastin matrices by adult rat vascular cells. J Tissue Eng Regen Med 2:106–116
Kothapalli CR, Gacchina CE, Ramamurthi A (2009a) Utility of hyaluronan oligomers and transforming growth factor-beta1 factors for elastic matrix regeneration by aneurysmal rat aortic smooth muscle cells. Tissue Eng 15:3247–3260
Kothapalli CR, Taylor PM, Smolenski RT, Yacoub MH, Ramamurthi A (2009b) Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng 15:501–511
Krishnamurthy R, Manning MC (2002) The stability factor: importance in formulation development. Curr Pharm Biotechnol 3:361–371
Kruithof BP, van Wijk B, Somi S, Kruithof-de Julio M, Perez Pomares JM, Weesie F et al (2006) BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 295:507–522
Kumbhani DJ, Healey NA, Birjiniuk V, Crittenden MD, Josa M, Treanor PR et al (2004) Determinants of regional myocardial acidosis during cardiac surgery. Surgery 136:190–198
Kurpinski K, Lam H, Chu J, Wang A, Kim A, Tsay E et al (2010) Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28:734–742
Kusuma S, Gerecht S (2010) Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther 8:1433–1445
Kwon JS, Park IK, Cho AS, Shin SM, Hong MH, Jeong SY et al (2009) Enhanced angiogenesis mediated by vascular endothelial growth factor plasmid-loaded thermo-responsive amphiphilic polymer in a rat myocardial infarction model. J Control Release 138:168–176
Lackey CA, Murthy N, Press OW, Tirrell DA, Hoffman AS, Stayton PS (1999) Hemolytic activity of pH-responsive polymer-streptavidin bioconjugates. Bioconjug Chem 10:401–405
Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015–1024
Lam MT, Wu JC (2012) Biomaterial applications in cardiovascular tissue repair and regeneration. Expert Rev Cardiovasc Ther 10:1039–1049
Lam NT, Currie PD, Lieschke GJ, Rosenthal NA, Kaye DM (2012) Nerve growth factor stimulates cardiac regeneration via cardiomyocyte proliferation in experimental heart failure. PLoS One 7:e53210
Langer R, Moses M (1991) Biocompatible controlled release polymers for delivery of polypeptides and growth factors. J Cell Biochem 45:340–345
Lanza RP, Langer R (2007) Principles of tissue engineering. Elsevier Academic Press, Amsterdam
Lau TT, Wang DA (2011) Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine. Expert Opin Biol Ther 11:189–197
Lee KY, Mooney DJ (2001) Hydrogels for tissue engineering. Chem Rev 101:1869–1879
Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM (2000a) VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898–901
Lee KY, Peters MC, Anderson KW, Mooney DJ (2000b) Controlled growth factor release from synthetic extracellular matrices. Nature 408:998–1000
Lee S, Jilani SM, Nikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169:681–691
Lee K, Silva EA, Mooney DJ (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8:153–170
Leeper NJ, Hunter AL, Cooke JP (2010) Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122:517–526
Leger AJ, Covic L, Kuliopulos A (2006) Protease-activated receptors in cardiovascular diseases. Circulation 114:1070–1077
Lendlein A, Jiang H, Junger O, Langer R (2005) Light-induced shape-memory polymers. Nature 434:879–882
Leor J, Amsalem Y, Cohen S (2005) Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Ther 105:151–163
Li S, Lao J, Chen BP, Li YS, Zhao Y, Chu J et al (2003) Genomic analysis of smooth muscle cells in 3-dimensional collagen matrix. FASEB J 17:97–99
Li D, Zhang C, Song F, Lubenec I, Tian Y, Song QH (2009a) VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration. Microvasc Res 77:134–142
Li B, Davidson JM, Guelcher SA (2009b) The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 30:3486–3494
Light N, Champion AE (1984) Characterization of muscle epimysium, perimysium and endomysium collagens. Biochem J 219:1017–1026
Lin CC, Anseth KS (2009) Controlling affinity binding with peptide-functionalized poly(ethylene glycol) hydrogels. Adv Funct Mater 19:2325–2331
Lin YD, Yeh ML, Yang YJ, Tsai DC, Chu TY, Shih YY et al (2010) Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 122:939512
Liu XM, Wang LS, Wang L, Huang J, He C (2004) The effect of salt and pH on the phase-transition behaviors of temperature-sensitive copolymers based on N-isopropylacrylamide. Biomaterials 25:5659–5666
Liu X, Won Y, Ma PX (2005) Surface modification of interconnected porous scaffolds. J Biomed Mater Res A 74:84–91
Liu Y, Sun L, Huan Y, Zhao H, Deng J (2006) Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg 30:103–107
Lo H, Kadiyala S, Guggino SE, Leong KW (1996) Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J Biomed Mater Res 30:475–484
Longo GM, Xiong WF, Greiner TC, Zhao Y, Fiotti N, Baxter BT (2002) Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 110:625–632
Lu L, Stamatas GN, Mikos AG (2000) Controlled release of transforming growth factor beta 1 from biodegradable polymer microparticles. J Biomed Mater Res 50:440–451
Lu LC, Yaszemski MJ, Mikos AG (2001) TGF-beta 1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am 83A: S82–S91
Lu J-M, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q et al (2009) Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn 9:325–341
Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47–55
Lutolf MP, Lauer-Fields JL, Schmoekel HG, Metters AT, Weber FE, Fields GB et al (2003a) Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proc Natl Acad Sci U S A 100:5413–5418
Lutolf MR, Weber FE, Schmoekel HG, Schense JC, Kohler T, Muller R et al (2003b) Repair of bone defects using synthetic mimetics of collagenous extracellular matrices. Nat Biotechnol 21:513–518
MacArthur JW Jr, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A et al (2013) Sustained release of engineered stromal cell-derived factor 1-alpha from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction. Circulation 128:000343
Mahabeleshwar GH, Feng W, Reddy K, Plow EF, Byzova TV (2007) Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 101: 570–580
Majesky MW, Dong XR, Regan JN, Hoglund VJ (2011) Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circ Res 108:365–377
Malemud CJ (2006) Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 11:1696–1701
Mann BK, Schmedlen RH, West JL (2001) Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22:439–444
Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS (2010) Stability of protein pharmaceuticals: an update. Pharm Res 27:544–575
Mano JF, Silva GA, Azevedo HS, Malafaya PB, Sousa RA, Silva SS et al (2007) Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends. J R Soc Interface 4:999–1030
Mark Saltzman W, Baldwin SP (1998) Materials for protein delivery in tissue engineering. Adv Drug Deliv Rev 33:71–86
Markovsky E, Baabur-Cohen H, Eldar-Boock A, Omer L, Tiram G, Ferber S et al (2012) Administration, distribution, metabolism and elimination of polymer therapeutics. J Control Release 161:446–460
Marmur JD, Poon M, Rossikhina M, Taubman MB (1992) Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. Circulation 86:III53–III60
Matsusaki M, Akashi M (2005) Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering. Biomacromolecules 6:3351–3356
Maynard HD, Hubbell JA (2005) Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater 1:451–459
Meinel L, Illi OE, Zapf J, Malfanti M, Merkle HP, Gander B (2001) Stabilizing insulin-like growth factor-I in poly(D, L-lactide-co-glycolide) microspheres. J Control Release 70: 193–202
Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V, Zichner L et al (2004) Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng 32:112–122
Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, Oettgen P et al (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103:194–202
Meloni M, Caporali A, Graiani G, Lagrasta C, Katare R, Van Linthout S et al (2010) Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 106:1275–1284
Mikos AG, Lyman MD, Freed LE, Langer R (1994) Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 15:55–58
Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu HH, Kandel R et al (2006) Engineering complex tissues. Tissue Eng 12:3307–3339
Miner EC, Miller WL (2006) A look between the cardiomyocytes: the extracellular matrix in heart failure. Mayo Clin Proc 81:71–76
Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53:283–318
Mooney DJ, Baldwin DF, Suh NP, Vacanti JP, Langer R (1996) Novel approach to fabricate porous sponges of poly(D, L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17:1417–1422
Mukherjee R, Brinsa TA, Dowdy KB, Scott AA, Baskin JM, Deschamps AM et al (2003) Myocardial infarct expansion and matrix metalloproteinase inhibition. Circulation 107: 618–625
Murakami M, Nguyen LT, Zhuang ZW, Moodie KL, Carmeliet P, Stan RV et al (2008) The FGF system has a key role in regulating vascular integrity. J Clin Invest 118:3355–3366
Murray JB, Brown L, Langer R, Klagsburn M (1983) A micro sustained release system for epidermal growth factor. In Vitro 19:743–748
Muscari C, Bonafe F, Martin-Suarez S, Valgimigli S, Valente S, Fiumana E et al (2013) Restored perfusion and reduced inflammation in the infarcted heart after grafting stem cells with a hyaluronan-based scaffold. J Cell Mol Med 17:518–530
Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573
Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL et al (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 204:3037–3047
Nakagami H, Kaneda Y, Ogihara T, Morishita R (2005) Hepatocyte growth factor as potential cardiovascular therapy. Expert Rev Cardiovasc Ther 3:513–519
Nakayama M, Okano T, Miyazaki T, Kohori F, Sakai K, Yokoyama M (2006) Molecular design of biodegradable polymeric micelles for temperature-responsive drug release. J Control Release 115:46–56
Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK et al (2008) Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 118:1138–1145
Nataatmadja M, West J, West M (2006) Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm. Circulation 114:I371–I377
Nejjar I, Pieraggi MT, Thiers JC, Bouissou H (1990) Age-related changes in the elastic tissue of the human thoracic aorta. Atherosclerosis 80:199–208
Nelson DM, Hashizume R, Yoshizumi T, Blakney AK, Ma Z, Wagner WR (2014) Intramyocardial injection of a synthetic hydrogel with delivery of bFGF and IGF1 in a rat model of ischemic cardiomyopathy. Biomacromolecules 15:1–11
Nicodemus GD, Bryant SJ (2008) Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng Part B Rev 14:149–165
Nie SP, Wang X, Qiao SB, Zeng QT, Jiang JQ, Liu XQ et al (2010) Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model. J Zhejiang Univ Sci B 11:895–904
Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28:1123–1131
Okura Y, Brink M, Zahid AA, Anwar A, Delafontaine P (2001) Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J Mol Cell Cardiol 33:1777–1789
Oltman CL, Kane NL, Gutterman DD, Bar RS, Dellsperger KC (2000) Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab 279:E176–E181
Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE et al (2004) Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113:516–527
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–347
Panyam J, Labhasetwar V (2004) Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol Pharm 1:77–84
Pardue EL, Ibrahim S, Ramamurthi A (2008) Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering. Organogenesis 4:203–214
Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG (2005) Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26:7095–7103
Pasquinelli G, Vinci MC, Gamberini C, Orrico C, Foroni L, Guarnieri C et al (2009) Architectural organization and functional features of early endothelial progenitor cells cultured in a hyaluronan-based polymer scaffold. Tissue Eng Part A 15:2751–2762
Patel VA, Zhang QJ, Siddle K, Soos MA, Goddard M, Weissberg PL et al (2001) Defect in insulin-like growth factor-1 survival mechanism in atherosclerotic plaque-derived vascular smooth muscle cells is mediated by reduced surface binding and signaling. Circ Res 88:895–902
Pei Y, Chen J, Yang L, Shi L, Tao Q, Hui B et al (2004) The effect of pH on the LCST of poly (N-isopropylacrylamide) and poly(N-isopropylacrylamide-co-acrylic acid). J Biomater Sci Polym Ed 15:585–594
Peters MC, Isenberg BC, Rowley JA, Mooney DJ (1998) Release from alginate enhances the biological activity of vascular endothelial growth factor. J Biomater Sci Polym Ed 9:1267–1278
Petersen E, Gineitis A, Wagberg F, Angquist KA (2000) Activity of matrix metalloproteinase-2 and-9 in abdominal aortic aneurysms. Relation to size and rupture. Eur J Vasc Endovasc Surg 20:457–461
Pfeifle B, Hamann H, Fussganger R, Ditschuneit H (1987) Insulin as a growth regulator of arterial smooth muscle cells: effect of insulin of I.G.F.I. Diabete Metab 13:326–330
Phelps EA, Landazuri N, Thule PM, Taylor WR, Garcia AJ (2010) Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 107:3323–3328
Piao H, Kwon JS, Piao S, Sohn JH, Lee YS, Bae JW et al (2007) Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 28:641–649
Pintucci G, Yu PJ, Saponara F, Kadian-Dodov DL, Galloway AC, Mignatti P (2005) PDGF-BB induces vascular smooth muscle cell expression of high molecular weight FGF-2, which accumulates in the nucleus. J Cell Biochem 95:1292–1300
Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER (1977) Activated macrophages induce vascular proliferation. Nature 269:804–806
Purcell BP, Elser JA, Mu A, Margulies KB, Burdick JA (2012) Synergistic effects of SDF-1alpha chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials 33:7849–7857
Purcell BP, Lobb D, Charati MB, Dorsey SM, Wade RJ, Zellars KN et al (2014) Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition. Nat Mater 30: 653–661
Pyo R, Lee JK, Shipley JM, Curci JA, Mao DL, Ziporin SJ et al (2000) Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105:1641–1649
Rafii S, Heissig B, Hattori K (2002) Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9:631–641
Ramirez F (1996) Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Dev 6:309–315
Rane AA, Christman KL (2011) Biomaterials for the treatment of myocardial infarction: a 5-year update. J Am Coll Cardiol 58:2615–2629
Ranjan AK, Kumar U, Hardikar AA, Poddar P, Nair PD, Hardikar AA (2009) Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis. PLoS One 4:0007718
Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19:1029–1034
Rizzi SC, Ehrbar M, Halstenberg S, Raeber GP, Schmoekel HG, Hagenmuller H et al (2006) Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 7:3019–3029
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM et al (1986) Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 83:4167–4171
Robinson PN, Godfrey M (2000) The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 37:9–25
Robinson TF, Cohen-Gould L, Factor SM, Eghbali M, Blumenfeld OO (1988) Structure and function of connective tissue in cardiac muscle: collagen types I and III in endomysial struts and pericellular fibers. Scanning Microsc 2:1005–1015
Rocha FG, Sundback CA, Krebs NJ, Leach JK, Mooney DJ, Ashley SW et al (2008) The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 29:2884–2890
Rosengart TK, Lee LY, Patel SR, Kligfield PD, Okin PM, Hackett NR et al (1999) Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 230:466–470
Rosenkranz S (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63:423–432
Rozario T, DeSimone DW (2010) The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 341:126–140
Rutschow S, Li J, Schultheiss HP, Pauschinger M (2006) Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res 69:646–656
Saif J, Schwarz TM, Chau DY, Henstock J, Sami P, Leicht SF et al (2010) Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization. Arterioscler Thromb Vasc Biol 30:1897–1904
Saitow CB, Wise SG, Weiss AS, Castellot JJ, Kaplan DL (2013) Elastin biology and tissue engineering with adult cells. Biomol Concepts 4:103–211
Sakalihasan N, Limet R, Defawe OD (2005) Abdominal aortic aneurysm. Lancet 365:1577–1589
Salimath AS, Phelps EA, Boopathy AV, Che PL, Brown M, Garcia AJ et al (2012) Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats. PLoS One 7:30
Santo VE, Frias AM, Carida M, Cancedda R, Gomes ME, Mano JF et al (2009) Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. Biomacromolecules 10:1392–1401
Sarig U, Machluf M (2011) Engineering cell platforms for myocardial regeneration. Expert Opin Biol Ther 11:1055–1077
Satta J, Oiva J, Salo T, Eriksen H, Ohtonen P, Biancari F et al (2003) Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis. Ann Thorac Surg 76:681–688
Sauvage M, Hinglais N, Mandet C, Badier C, Deslandes F, Michel JB et al (1998) Localization of elastin mRNA and TGF-β1 in rat aorta and caudal artery as a function of age. Cell Tissue Res 291:305–314
Schini-Kerth VB (1999) Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J Endocrinol Invest 22:82–88
Schumacher B, Pecher P, von Specht BU, Stegmann T (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation 97:645–650
Scott RC, Rosano JM, Ivanov Z, Wang B, Chong PL, Issekutz AC et al (2009) Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 23:3361–3367
Sekine H, Shimizu T, Sakaguchi K, Dobashi I, Wada M, Yamato M et al (2013) In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat Commun 4:1399
Shao ZQ, Takaji K, Katayama Y, Kunitomo R, Sakaguchi H, Lai ZF et al (2006) Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ J 70:471–477
Sharma A, Sharma US (1997) Liposomes in drug delivery: progress and limitations. Int J Pharm 154:123–140
Sheridan MH, Shea LD, Peters MC, Mooney DJ (2000) Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Release 64:91–102
Shim WS, Yoo JS, Bae YH, Lee DS (2005) Novel injectable pH and temperature sensitive block copolymer hydrogel. Biomacromolecules 6:2930–2934
Shim WS, Kim SW, Lee DS (2006) Sulfonamide-based pH- and temperature-sensitive biodegradable block copolymer hydrogels. Biomacromolecules 7:1935–1941
Shimizu T, Sekine H, Yamato M, Okano T (2009) Cell sheet-based myocardial tissue engineering: new hope for damaged heart rescue. Curr Pharm Des 15:2807–2814
Shin YM, Lee YB, Kim SJ, Kang JK, Park JC, Jang W et al (2012) Mussel-inspired immobilization of vascular endothelial growth factor (VEGF) for enhanced endothelialization of vascular grafts. Biomacromolecules 13:2020–2028
Shirota T, He H, Yasui H, Matsuda T (2003) Human endothelial progenitor cell-seeded hybrid graft: proliferative and antithrombogenic potentials in vitro and fabrication processing. Tissue Eng 9:127–136
Siepe M, Giraud MN, Pavlovic M, Receputo C, Beyersdorf F, Menasche P et al (2006) Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg 132:124–131
Siepe M, Giraud MN, Liljensten E, Nydegger U, Menasche P, Carrel T et al (2007) Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif Organs 31:425–433
Silva EA, Kim E-S, Kong HJ, Mooney DJ (2008) Material-based deployment enhances efficacy of endothelial progenitor cells. Proc Natl Acad Sci U S A 105:14347–14352
Silva AK, Richard C, Bessodes M, Scherman D, Merten OW (2009) Growth factor delivery approaches in hydrogels. Biomacromolecules 10:9–18
Simionescu A, Philips K, Vyavahare N (2005) Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 334:524–532
Simons M, Ware JA (2003) Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov 2:863–871
Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H et al (2002) Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105:788–793
Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr (2007) A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25:2350–2357
Singer CA, Salinthone S, Baker KJ, Gerthoffer WT (2004) Synthesis of immune modulators by smooth muscles. Bioessays 26:646–655
Sivaraman B, Ramamurthi A (2013) Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. Acta Biomater 9: 6511–6525
Sivaraman B, Bashur C, Ramamurthi A (2012) Advances in biomimetic regeneration of elastic matrix structures. Drug Deliv Transl Res 2:323–350
Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F (1999) Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18:882–892
Sone M, Itoh H, Yamashita J, Yurugi-Kobayashi T, Suzuki Y, Kondo Y et al (2003) Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation 107:2085–2088
Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ et al (1997) Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Release 43:197–212
Song Y, Kamphuis MM, Zhang Z, Sterk LM, Vermes I, Poot AA et al (2010) Flexible and elastic porous poly(trimethylene carbonate) structures for use in vascular tissue engineering. Acta Biomater 6:1269–1277
Soontornworajit B, Zhou J, Shaw MT, Fan TH, Wang Y (2010) Hydrogel functionalization with DNA aptamers for sustained PDGF-BB release. Chem Commun 46:1857–1859
Spies M, Nesic O, Barrow RE, Perez-Polo JR, Herndon DN (2001) Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther 8:1409–1415
Spinale FG (2007) Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87:1285–1342
Sukmana I (2012) Bioactive polymer scaffold for fabrication of vascularized engineering tissue. J Artif Organs 15:215–224
Sumaru K, Kameda M, Kanamori T, Shinbo T (2004) Reversible and efficient proton dissociation of spirobenzopyran-functionalized poly(N-isopropylacrylamide) in aqueous solution triggered by light irradiation and temporary temperature rise. Macromolecules 37:7854–7856
Sylvester A, Sivaraman B, Deb P, Ramamurthi A (2013) Nanoparticles for localized delivery of hyaluronan oligomers towards regenerative repair of elastic matrix. Acta Biomater 9: 9292–9302
Tabata Y (2003) Tissue regeneration based on growth factor release. Tissue Eng 9:S5–S15
Tabata Y, Ikada Y, Morimoto K, Katsumata H, Yabuta T, Iwanaga K et al (1999) Surfactant-free preparation of biodegradable hydrogel microspheres for protein release. J Bioact Compat Polym 14:371–384
Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T et al (2008) Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol 52:1858–1865
Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer DB et al (2010) Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 285:17556–17563
Taniyama Y, Morishita R, Nakagami H, Moriguchi A, Sakonjo H, Shokei K et al (2000) Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 102: 246–252
Tayalia P, Mooney DJ (2009) Controlled growth factor delivery for tissue engineering. Adv Mater 21:3269–3285
ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857–869
Tengood JE, Kovach KM, Vescovi PE, Russell AJ, Little SR (2010) Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis. Biomaterials 31: 7805–7812
Tengood JE, Ridenour R, Brodsky R, Russell AJ, Little SR (2011) Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A 17:1181–1189
Tessmar JK, Gopferich AM (2007) Matrices and scaffolds for protein delivery in tissue engineering. Adv Drug Deliv Rev 59:274–291
Thie M, Schlumberger W, Semich R, Rauterberg J, Robenek H (1991) Aortic smooth muscle cells in collagen lattice culture: effects on ultrastructure, proliferation and collagen synthesis. Eur J Cell Biol 55:295–304
Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, Murphy M et al (2009) Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res 104:1410–1420
Tsou R, Isik FF (2001) Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells. Mol Cell Biochem 224:81–89
Tucka J, Bennett M, Littlewood T (2012) Cell death and survival signalling in the cardiovascular system. Front Biosci (Landmark Ed) 17:248–261
Ulijn RV, Bibi N, Jayawarna V, Thornton PD, Todd SJ, Mart RJ et al (2007) Bioresponsive hydrogels. Mater Today 10:40–48
Urbich C, Dimmeler S (2004) Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343–353
Vasita R, Katti DS (2006) Growth factor-delivery systems for tissue engineering: a materials perspective. Expert Rev Med Devices 3:29–47
Venkataraman L, Sivaraman B, Vaidya P, Ramamurthi A (2014) Nanoparticulate delivery of agents for induced elastogenesis in 3-dimensional collagenous matrices. J Tissue Eng Regen Med. doi:10.1002/term.1889
Walpoth BH, Zammaretti P, Cikirikcioglu M, Khabiri E, Djebaili MK, Pache JC et al (2007) Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg 133:1163–1170
Waltenberger J (2005) Growth factor signal transduction defects in the cardiovascular system. Cardiovasc Res 65:574–580
Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J et al (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97:1142–1151
Wang ZZ, Au P, Chen T, Shao Y, Daheron LM, Bai H et al (2007) Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 25: 317–318
Wang X, Wenk E, Zhang X, Meinel L, Vunjak-Novakovic G, Kaplan DL (2009) Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J Control Release 134:81–90
Wang Y, Ait-Oufella H, Herbin O, Bonnin P, Ramkhelawon B, Taleb S et al (2010a) TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 120:422–432
Wang H, Zhang X, Li Y, Ma Y, Zhang Y, Liu Z et al (2010b) Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant 29:881–887
Weinberg CB, Bell E (1986) A blood vessel model constructed from collagen and cultured vascular cells. Science 231:397–400
Welch PM (2005) A tunable dendritic molecular actuator. Nano Lett 5:1279–1283
Wentzel JJ, Corti R, Fayad ZA, Wisdom P, Macaluso F, Winkelman MO et al (2005) Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. J Am Coll Cardiol 45:846–854
Wiernicki I, Cnotliwy M, Baranowska-Bosiacka I, Urasinska E, Kwas A, Bober J et al (2008) Elastin degradation within the abdominal aortic aneurysm wall—relationship between intramural pH and adjacent thrombus formation. Eur J Clin Invest 38:883–887
Xiao Q, Wang G, Luo Z, Xu Q (2010) The mechanism of stem cell differentiation into smooth muscle cells. Thromb Haemost 104:440–448
Yablonka-Reuveni Z, Seger R, Rivera AJ (1999) Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem 47:23–42
Yamamoto T, Kozawa O, Tanabe K, Akamatsu S, Matsuno H, Dohi S et al (2001) Involvement of p38 MAP kinase in TGF-beta-stimulated VEGF synthesis in aortic smooth muscle cells. J Cell Biochem 82:591–598
Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T et al (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92–96
Yang HS, Bhang SH, Kim IK, Lee TJ, Kang JM, Lee DH et al (2012) In situ cardiomyogenic differentiation of implanted bone marrow mononuclear cells by local delivery of transforming growth factor-beta1. Cell Transplant 21:299–312
Yannas IV (2004) Natural materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds) Biomaterials science: an introduction to materials in medicine. Academic, San Diego, CA
Yin X, Hoffman AS, Stayton PS (2006) Poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers that respond sharply to temperature and pH. Biomacromolecules 7:1381–1385
Yun Y, Shanov V, Tu Y, Schulz MJ, Yarmolenko S, Neralla S et al (2006) A multi-wall carbon nanotube tower electrochemical actuator. Nano Lett 6:689–693
Zaruba MM, Franz WM (2010) Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy. Expert Opin Biol Ther 10:321–335
Zhang G, Hu Q, Braunlin EA, Suggs LJ, Zhang J (2008) Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng Part A 14:1025–1036
Zhao Q, Egashira K, Inoue S, Usui M, Kitamoto S, Ni W et al (2002) Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 105:1110–1115
Zhu XH, Wang CH, Tong YW (2009) In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A 89:411–423
Zhuang Y, Chen X, Xu M, Zhang LY, Xiang F (2009) Chemokine stromal cell-derived factor 1/CXCL12 increases homing of mesenchymal stem cells to injured myocardium and neovascularization following myocardial infarction. Chin Med J 122:183–187
Zieris A, Prokoph S, Levental KR, Welzel PB, Grimmer M, Freudenberg U et al (2010) FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 31:7985–7994
Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA (2001) Covalently conjugated VEGF–fibrin matrices for endothelialization. J Control Release 72:101–113
Zisch AH, Lutolf MP, Ehrbar M, Raeber GP, Rizzi SC, Davies N et al (2003) Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17:2260–2262
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sivaraman, B., Ramamurthi, A. (2015). Growth Factor Delivery Matrices for Cardiovascular Regeneration. In: Suuronen, E., Ruel, M. (eds) Biomaterials for Cardiac Regeneration. Springer, Cham. https://doi.org/10.1007/978-3-319-10972-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-10972-5_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10971-8
Online ISBN: 978-3-319-10972-5
eBook Packages: EngineeringEngineering (R0)